Denali Therapeutics Inc.
Kinase inhibitors and uses thereof
Last updated:
Abstract:
The present disclosure relates generally to compounds and compositions, intermediates, processes for their preparation, and their use as kinase inhibitors.
Status:
Grant
Type:
Utility
Filling date:
14 Nov 2019
Issue date:
21 Dec 2021